
KYNAM CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | CGON | 2.01M | $80.77M |
![]() | MBX | 2.00M | $35.00M |
![]() | PRQR | 1.65M | $3.51M |
![]() | DSGN | 1.03M | $7.75M |
![]() | IMCR | 1.01M | $36.67M |
![]() | BNR | 995K | $8.61M |
![]() | TVTX | 950K | $22.70M |
![]() | APLS | 809K | $18.30M |
![]() | PHVS | 675K | $16.84M |
![]() | KALV | 606K | $7.38M |
![]() | AMRN | 576K | $9.44M |
![]() | URGN | 282K | $6.94M |
![]() | EWTX | 254K | $4.12M |
![]() | UTHR | 68K | $20.01M |

CG Oncology, Inc. Common stock
CGON
Shares Held
2.01M
Value
$80.77M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
2.00M
Value
$35.00M

ProQR Therapeutics N.V.
PRQR
Shares Held
1.65M
Value
$3.51M

Design Therapeutics, Inc.
DSGN
Shares Held
1.03M
Value
$7.75M

Immunocore Holdings plc
IMCR
Shares Held
1.01M
Value
$36.67M

Burning Rock Biotech Limited
BNR
Shares Held
995K
Value
$8.61M

Travere Therapeutics, Inc.
TVTX
Shares Held
950K
Value
$22.70M

Apellis Pharmaceuticals, Inc.
APLS
Shares Held
809K
Value
$18.30M

Pharvaris N.V.
PHVS
Shares Held
675K
Value
$16.84M

KalVista Pharmaceuticals, Inc.
KALV
Shares Held
606K
Value
$7.38M

Amarin Corporation plc
AMRN
Shares Held
576K
Value
$9.44M

UroGen Pharma Ltd.
URGN
Shares Held
282K
Value
$6.94M

Edgewise Therapeutics, Inc.
EWTX
Shares Held
254K
Value
$4.12M

United Therapeutics Corporation
UTHR
Shares Held
68K
Value
$20.01M
